Page 16 - TROMBOCITOPENIA INMUNE PRIMARIA (PTI)

Bibliografía recomendada
Rituximab
Deshayes S, Khellaf M, Zarour A, Layese R, Fain O, Terriou L, et al. Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-ritux. Am J Hematol. 2019 Dec;94(12):1314-24. [Pubmed]
Lucchini E, Zaja F, Bussel J. Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019? Haematologica. 2019 Jun;104(6):1124-35. [Pubmed]
Avatrombopag
Jurczak W, Chojnowski K, Mayer J, Krawczyk K, Jamieson BD, Tian W, Allen LF. Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia. Br J Haematol. 2018 Nov;183(3):479-90. [Pubmed]
Fostamatinib
Bussel J, Arnold DM, Grossbard E, Mayer J, Trelinski J, Homenda W, et al. Fostamatinib
for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials. Am J Hematol. 2018 Jul;93(7):921-30. [Pubmed]
Oseltamivir y atorvastatina
Kong Y, Cao XN, Zhang XH, Shi MM, Lai YY, Wang Y, et al. Atorvastatin enhances bone marrow endothelial cell function in corticosteroid-resistant immune thrombocytopenia patients. Blood. 2018 Mar 15;131(11):1219-33. [Pubmed]
Revilla N, Corral J, Miñano A, Mingot-Castellano ME, Campos RM, Velasco F, et al. Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content. Platelets. 2019;30(6):743-51. [Pubmed]
Preparación para la cirugía
Al-Samkari H, Marshall AL, Goodarzi K, Kuter DJ. Romiplostim for the management of perioperative thrombocytopenia. Br J Haematol. 2018 Jul;182(1):06-113. [Pubmed]
Arnold DM, Jamula E, Heddle NM, Cook RJ, Hsia C, Sholzberg M, et al. Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and Rationale. Thromb Haemost. 2019 Mar;119(3):500-7. [Pubmed]
Zaja F, Barcellini W, Cantoni S, Carpenedo M, Caparrotti G, Carrai V, et al. Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study. Am J Hematol. 2016 May;91(5):E293-5. [Enalce]
PTI en el embarazo
González-López TJ, Olivera P, Jarque I, et al. Effect of pregnancy on the course of ITP pregnant women and their offspring. Results of a spanish case-series of 230 primary ITP pregnancies. ISTH Congress;2017.
Anticoagulación
liescu CA, Grines CL, Herrmann J, Yang EH, Cilingiroglu M, Charitakis K, et al. SCAI Expert consensus statement: Evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologıa intervencionista). Catheter Cardiovasc Interv. 2016 Apr;87(5):E202-23. [Pubmed]
Wang CL, Wu VC, Lee CH, Kuo CF, Chen YL, Chu PH, et al. Effectiveness and safety of non- vitamin-K antagonist oral anticoagulants versus warfarin in atrial fibrillation patients with thrombocytopenia. J Thromb Thrombolysis. 2019 May;47(4):512-519. [Pubmed]